Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-System Pharmacists

This activity will improve the knowledge and competence of pharmacists about the management of anticoagulant-related bleeding including recent guideline updates selecting appropriate reversal agents and dosing strategies clinical data regarding the efficacy and safety outcomes of reversal agents for oral anticoagulants and strategies to address formulary concerns including access to reversal agents streamlining administration waste prevention and institutional policy development to improve patient care.

Share

Program Content

Activities

FAQ: Anticoagulants and Major Bleeding
My Take on Compelling Audience Questions From the Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-System Pharmacists
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 30, 2021

Expires: December 29, 2022

DOAC Reversal
Reversing DOAC-Associated Major Bleeding—Follow the Data
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 05, 2022

Expires: January 04, 2023

Faculty

cover img faculity

Tyree H. Kiser, PharmD, FCCP, FCCM, BCCCP, BCPS

Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado Anschutz Medical Campus
Clinical Pharmacy Specialist – Critical Care
University of Colorado Hospital
Aurora, Colorado

cover img faculity

Charles “Kurt” Mahan, PharmD, PhC, FASHP, FCCP

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Alexion

AstraZeneca Rare Disease